Cargando…

PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy

BACKGROUND: Thyroid associated ophthalmopathy (TAO) is an autoimmune disease, which involves inflammation and tissue remodeling. Pentraxin-3 (PTX3) is a component of innate immune system and recently implicated in autoimmunity. This observation may indicate that PTX3 participates in the inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mou, Pei, Chen, Ziyu, Jiang, Lihong, Cheng, Jinwei, Wei, Ruili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838458/ https://www.ncbi.nlm.nih.gov/pubmed/29675428 http://dx.doi.org/10.1155/2018/5961974

Ejemplares similares

Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts
por: Diao, Jiale, et al.
Publicado: (2022)

Research progress and application of artificial intelligence in thyroid associated ophthalmopathy
por: Diao, Jiale, et al.
Publicado: (2023)

Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy
por: Jiang, Lihong, et al.
Publicado: (2020)

Identification of tRNA-Related Fragments and Their Potential Regulatory Effects in Thyroid-Associated Ophthalmopathy
por: Yue, Zifan, et al.
Publicado: (2022)

A Novel Competing Endogenous RNA Network Associated With the Pathogenesis of Graves’ Ophthalmopathy
por: Yue, Zifan, et al.
Publicado: (2021)

The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy
por: Huang, Xiao, et al.
Publicado: (2023)

Identification and validation of ferroptosis-related genes and immune cell infiltration in thyroid associated ophthalmopathy
por: Chen, Sainan, et al.
Publicado: (2023)

Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017)

Characterization of human tear proteome reveals differentially abundance proteins in thyroid-associated ophthalmopathy
por: Zhou, Xiaoqing, et al.
Publicado: (2022)

Altered Corneal Nerves in Chinese Thyroid-Associated Ophthalmopathy Patients Observed by In Vivo Confocal Microscopy
por: Wu, Lian-Qun, et al.
Publicado: (2019)

Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022)

An Intelligent Diagnostic System for Thyroid-Associated Ophthalmopathy Based on Facial Images
por: Huang, Xiao, et al.
Publicado: (2022)

The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
por: Huang, Yazhuo, et al.
Publicado: (2018)

Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy
por: Zhou, Ling-Yun, et al.
Publicado: (2017)

Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)

Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy
por: Xu, Zhihui, et al.
Publicado: (2022)

Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology
por: Li, Kaijun, et al.
Publicado: (2019)

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy
por: McCorquodale, Tom, et al.
Publicado: (2012)

Common Immunosuppressive Monotherapy for Graves’ Ophthalmopathy: A Meta-Analysis
por: Mou, Pei, et al.
Publicado: (2015)

Altered dynamic brain activity and functional connectivity in thyroid‐associated ophthalmopathy
por: Jiang, Wen‐Hao, et al.
Publicado: (2023)

Outcome of thyroid associated ophthalmopathy treated by radiation therapy
por: Abboud, Mirna, et al.
Publicado: (2011)

Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)

Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020)

Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy
por: Adetunji, Modupe O., et al.
Publicado: (2022)

Pentraxin 3 (PTX3) promoter methylation associated with PTX3 plasma levels and neutrophil to lymphocyte ratio in coronary artery disease
por: Guo, Tang-Meng, et al.
Publicado: (2016)

Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway
por: Sun, Anqi, et al.
Publicado: (2023)

Correlation between Peripheral T Cell Subsets and the Activity of Thyroid-Associated Ophthalmopathy
por: Hu, Hong, et al.
Publicado: (2022)

Disrupted Topological Organization of the Brain Structural Network in Patients With Thyroid-Associated Ophthalmopathy
por: Wu, Qian, et al.
Publicado: (2021)

Increased brain iron in patients with thyroid-associated ophthalmopathy: a whole-brain analysis
por: Hu, Hao, et al.
Publicado: (2023)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy
por: Bagheri, Abbas, et al.
Publicado: (2020)

Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy
por: Higashiyama, Tomoaki, et al.
Publicado: (2018)

Inflammatory swelling of the inferior oblique muscle in thyroid associated ophthalmopathy
por: Kakizaki, Hirohiko
Publicado: (2007)

Atypical Presentation of Hashimoto’s Disease in an Adolescent: Thyroid-Associated Ophthalmopathy
por: Kırmızıbekmez, Heves, et al.
Publicado: (2014)

Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development
por: Huang, Yazhuo, et al.
Publicado: (2020)

Analysis of macular blood flow changes in thyroid associated ophthalmopathy
por: Zhang, Xiaohan, et al.
Publicado: (2022)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

The Effect of Inferior Rectus Muscle Thickening on Intraocular Pressure in Thyroid-Associated Ophthalmopathy
por: Li, Xiuhong, et al.
Publicado: (2021)

Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
por: Suzuki, Nami, et al.
Publicado: (2018)

Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy
por: Tu, Yunhai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qhbge1sr66meiq6c7mmdaqge0v